Skip to main content
letter
. 2015 Jul 27;6(6):697–705. doi: 10.1007/s13244-015-0422-0

Fig. 3.

Fig. 3

Flowchart for the monitoring of Kawasaki disease with current imaging modalities starting at 1 year after the disease. aWhen information is lacking about coronary arterial aneurysms (CAA) status, a calcium score may be indicated as a screening method. If positive, a CMRI with adenosine should be performed. bLong-term follow-up (cardiovascular counselling) of risk group 1 may be dictated by national health care policies and future studies. cAccording to the availability and experience of a centre with (low-dose) CT angiography. dWhich of the different revascularization options best improves prognosis is unclear to date. eAdditional tests to evaluate for progression to stenotic lesions